The kit includes the essentials needed for self-administration and is designed for individuals who have been prescribed or recommended B12 therapy
The other authors declare they have no financial interests
Individual responses vary significantly based on genetic factors, body composition, and baseline metabolic function
Semaglutide produced less weight loss than tirzepatide head-to-head, about 14% versus 20%. Its body-composition substudy measured a roughly 62:38 fat-to-lean loss split by mass, compared with about 75:25 for tirzepatide in a separate trial. The scan overstates muscle loss because lean mass includes water and organ tissue
Non-alcoholic fatty liver disease (NAFLD): assessment and management NICE NG49
A., Khorvash, F., Askari, G